350 Add to cart TESAMORELIN INJECTOR PEN 3ML Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone, GHRH(1-44), developed by Theratechnologies
In Novo Nordisk's clinical late-phase trial for obesity without type 2 diabetes, which included more than 300 adults, the participants who took the pill once daily lost an average of 16.6% of their body weight, or 39 pounds , compared with 2.7%, or 6 pounds, for those on a placebo
Do you have any supporting materials you can share (e.g., forms, flyers, marketing collateral, or helpful links)
optimized molecular str Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd